events_2

Biointron is thrilled to announce our participation in CPHI Japan 2025, one of Asia’s most influential pharmaceutical events, set to take place from April 9-11, 2025, in Tokyo, Japan.

Biointron is delighted to announce our participation in the NextGen Biomed Europe 2025 Conference, happening on March 12-14, 2025, in London, UK.

Biointron is excited to announce our participation in the World ADC London 2025 Conference, set to take place March 3-6, 2025, in London, UK.

Biointron is thrilled to announce that Biointron will be participating in the upcoming 24th Annual PepTalk Protein Science Conference, taking place January 13-16, 2025, in San Diego, California.

Biointron celebrated milestones at the 2024 Year-End Networking Party, highlighting partnerships, achievements, and a vision for the future of antibody innovation.

Discovery on Target 2024 in Boston highlighted drug discovery. Biointron shares event insights advancing antibody therapeutics and translational science.

The 15th World Bispecifics Summit in Boston showcased breakthroughs. Biointron shares highlights shaping the future of bispecific antibody therapeutics.

The 12th Immuno-Oncology Summit in Philadelphia spotlighted antibody therapeutics. Biointron shares event highlights driving progress in cancer immunotherapy.

BIO Asia 2024 in Taiwan featured breakthroughs in biotech and antibodies. Biointron shares key takeaways that define trends in global biologics and innovation.

BIX 2024 in Seoul spotlighted biotech and antibody advances. Biointron reports event highlights shaping innovation across discovery, development, and therapeutics.

The Next-Gen Immuno-Oncology Conference 2024 in Boston featured advances in immunotherapy. Biointron shares insights driving future antibody-based treatments.

AET Europe 2024 in London spotlighted antibody innovation. Biointron shares event takeaways on discovery, engineering, and development shaping the therapeutic pipeline.

BIO 2024 in San Diego showcased biotech innovation. Biointron reports highlights on antibody discovery, engineering, and collaborations shaping the future of biologics.

Explore key highlights from PEGS 2024, featuring breakthroughs in antibody engineering, immunotherapy, ADC development, AI-driven discovery, and protein science.

Discover highlights from CAS 2024, featuring advances in cancer immunotherapy, Alzheimer’s research, protein bioinformatics, and antibody engineering breakthroughs.